TIMH
RMD icon

Tilt Investment Management Holdings’s ResMed RMD Stock Holding History

Tilt Investment Management Holdings’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,771
Closed -$387K – 145
2023
Q2 		$387K Hold
1,771
– – 0.26% 102
2023
Q1 		$382K Buy
1,771
+100
+6% +$21.7K 0.28% 100
2022
Q4 		$348K Buy
+1,671
New +$367K 0.29% 101

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Tilt Investment Management Holdings's RMD Position: Q3 2023 in Review

Tilt Investment Management Holdings sold out of ResMed (RMD) in Q3 2023, closing a stake of 1,771 shares — an estimated $387K sold.

Tilt Investment Management Holdings first reported a position in RMD in Q4 2022 and held it in 3 quarters. The position peaked at $387K in Q2 2023. 658 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Tilt Investment Management Holdings reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Tilt Investment Management Holdings sold 1,771 ResMed shares in Q3 2023, an estimated $387K.
  • Tilt Investment Management Holdings first reported a position in ResMed in Q4 2022 and held it in 3 quarters.
  • Tilt Investment Management Holdings's ResMed position peaked at $387K in Q2 2023.
  • 658 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.